Establishment and characterization of a novel anti-DNAM-1 monoclonal antibody

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

Volumn 32, Issue 1, 2013, Pages 60-64

  Yamashita, Yumi ^a,b   Abe, Fumie ^a,b   Hirochika, Rei ^a,b   Tahara Hanaoka, Satoko ^a,b   Shibuya, Akira ^a,b   Shibuya, Kazuko ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD155 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY TX42; MONOCLONAL ANTIBODY TX92; NECTIN 2; PROTEIN DNAM 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; GRAFT VERSUS HOST REACTION; MOLECULAR INTERACTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SPLEEN CELL; T CELL DEPLETION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD8-POSITIVE T-LYMPHOCYTES; DNA PRIMERS; GRAFT VS HOST DISEASE; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES;

MUS;

EID: 84876747810     PISSN: None     EISSN: 21679436     Source Type: Journal    
DOI: 10.1089/mab.2012.0083     Document Type: Article

References (14)

1. Shibuya A, Campbell D, Hannum C, Yssel H, Franz-Bacon K, McClanahan T, Kitamura T, Nicholl J, Sutherland GR, and Lanier LL: DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 1996;4:573-581.
2. Tahara-Hanaoka S, Miyamoto A, Hara A, Honda S, Shibuya K, and Shibuya A: Identification and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligands. Biochem Biophys Res Commun 2005;329:996-1000.
3. Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B, Cantoni C, Grassi J, Marcenaro S, and Reymond N: Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 2003;198:557-567.
4. Tahara-Hanaoka S, Shibuya K, Onoda Y, Zhang H, Yamazaki S, Miyamoto A, Honda S, Lanier LL, and Shibuya A: Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Int Immunol 2004;16:533.
5. Tahara-Hanaoka S, Shibuya K, Kai H, Miyamoto A, Morikawa Y, Ohkochi N, Honda S, and Shibuya A: Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor. Blood 2006;107:1491-1496.
6. Iguchi-Manaka A, Kai H, Yamashita Y, Shibata K, Tahara- Hanaoka S, Honda S, Yasui T, Kikutani H, Shibuya K, and Shibuya A: Accelerated tumor growth in mice deficient in DNAM-1 receptor. J Exp Med 2008;205:2959-2964.
7. El-Sherbiny YM, Meade JL, Holmes TD, McGonagle D, Mackie SL, Morgan AW, Cook G, Feyler S, Richards SJ, and Davies FE: The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells. Cancer Res 2007;67:8444-8449.
8. Verhoeven DHJ, de Hooge ASK, Mooiman ECK, Santos SJ, ten Dam MM, Gelderblom H, Melief CJM, Hogendoorn PCW, Egeler RM, and van Tol MJD: NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways. Mol Immunol 2008;45:3917- 3925.
9. Shibuya K, Shirakawa J, Kameyama T, Honda S, Tahara- Hanaoka S, Miyamoto A, Onodera M, Sumida T, Nakauchi H, Miyoshi H, and Shibuya A: CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J Exp Med 2003;198:1829-1839.
10. Nabekura T, Shibuya K, Takenaka E, Kai H, Shibata K, Yamashita Y, Harada K, Tahara-Hanaoka S, Honda S, and Shibuya A: Critical role of DNAX accessory molecule-1 (DNAM-1) in the development of acute graft-versus-host disease in mice. Proc Natl Acad Sci USA 2010;107:18593-18598.
11. Kojima H, Kanada H, Shimizu S, Kasama E, Shibuya K, Nakauchi H, Nagasawa T, and Shibuya A: CD226 mediates platelet and megakaryocytic cell adhesion to vascular endothelial cells. J Biol Chem 2003;278:36748-36753.
12. Yoshimura A, Shiku H, and Nakayama E: Rejection of an IA + variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4 + and CD4-CD8-T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice. J Immunol 1993;150:4900-4910.
13. Uchida J, Hamaguchi Y, Oliver JA, Ravetch JV, Poe JC, Haas KM, and Tedder TF: The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J Exp Med 2004;199:1659-1669.
14. Nimmerjahn F, and Ravetch JV: Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Sci Signal 2005;310:1510.